Research is needed to help illustrate the size and nature of access gaps so that we can design better coverage policies. Ultimately, there is a need for policymakers to recognize that factors unrelated to whether an individual has a medical necessity for treatment can affect whether or not a person is likely to receive these medications, says study lead author Meghan Podolsky (SPH24), research fellow in the Department of Global Health and an SPH alum who completed the MS program in epidemiology last year
Nature 520 , 5762 (2015)
Key takeaways Systemic lupus erythematosus (SLE) is a chronic autoimmune condition characterized by widespread inflammation that can affect various parts of the body, including the skin, joints, blood vessels, and organs
Raw diets have been touted by some as having health benefits, such as higher digestibility, more diverse gastrointestinal microbiomes, and better owner-perceived health
Long-term treatment of erythropoietic protopotphyria with cysteine
The review article written by Murielle's team is well worth reading
